Stichting Radboud University Medical Center
Stichting Radboud University Medical Center is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
Phase 1/2 study with an open-label dose escalation phase followed by a randomized, double-blind phase of SLN124 in patients with Polycythemia Vera
Sponsor Silence Therapeutics PLC
- Start (EU)
- Latest update
- Estimated end
A Phase 1, Multicentre, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single IV Dose of Rezafungin Acetate in Paediatric Subjects from Birth to <18 Years of Age, Receiving Systemic Antifungals as Prophylaxis for Invasive Fungal Infection or to Treat a Suspected or Confirmed Fungal Infection
Sponsor Mundipharma Research Limited
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Stichting Radboud University Medical Center?
The 2026-10-09 snapshot links Stichting Radboud University Medical Center to 2 distinct CTIS trials. Recorded services include Laboratory services, Bioanalytical lab. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Stichting Radboud University Medical Center?
The most frequently recorded therapeutic areas are Haematological Malignancies. Recorded phases include Phase 1, Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Stichting Radboud University Medical Center conducted?
The linked trials record locations in 5 countries, including Germany, Spain, Bulgaria, Italy, Poland. These are trial locations, not confirmed office locations or countries where Stichting Radboud University Medical Center delivered services.
What can this page tell me about Stichting Radboud University Medical Center's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Stichting Radboud University Medical Center. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Stichting Radboud University Medical Center